PETV
vs
S&P 500
PETV
S&P 500
Over the past 12 months, PETV has outperformed S&P 500, delivering a return of +30% compared to the S&P 500's +12% growth.
Stocks Performance
PETV vs S&P 500
Performance Gap
PETV vs S&P 500
Performance By Year
PETV vs S&P 500
Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.
PetVivo Holdings Inc
Glance View
PetVivo Holdings, Inc. is a veterinary biotech and biomedical device company. The company is headquartered in Edina, Minnesota. The company went IPO on 2012-07-10. The firm is primarily engaged in the business of translating or adapting human biotech and medical technology into products for commercialization in the veterinary market to treat companion animals such as dogs, horses, cats, and other animals suffering from osteoarthritis and other afflictions. The Company’s pipeline product, Kush, is comprised of a patented, gel-like, protein-based biomaterial which may be injected into the afflicted body parts of companion animals suffering from osteoarthritis. Kush’s predecessor formulation completed a Gel-Del-sponsored 145 patient First-in-Man IDE clinical trial using the novel thermoplastic biomaterial as dermal filler for human cosmetic applications.
